Surrey Heartlands

Joint Formulary & PAD

Leniolisib - Activated phosphoinositide 3-kinase delta syndrome (APDS)

You are here : Home > Formulary Search > Leniolisib - Activated phosphoinositide 3-kinase delta syndrome (APDS)

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Tablets
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
NHSE
NICE
SPC
Restrictions / Comments :
Important

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Leniolisib
Indication :
Activated phosphoinositide 3-kinase delta syndrome (APDS)
Group Name :
Keywords :
APDS
Brand Names Include :
Joenja
Important Information :

For 12 Years and over.

Immunology Consultants only

 

Latest Additions Date From :
08 Oct 2025
Latest Additions Date To :
08 Nov 2025
Guidelines :
Supporting Documents :
0

Committee Recommendations (1)

03 Oct 25 - RSFT DTC

RSFT DTC October 2025

Other Indications

Below are listed other indications that Leniolisib is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Activated phosphoinositide 3-kinase delta syndrome (APDS) .

  • No records returned.